Apixaban Intermediate CAS 545445-44-1 Maʻemaʻe >98.0% (HPLC)
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui o 3-Morpholino-1-(4-(2-Oxopiperidin-1-yl)phenyl)-5,6-Dihydropyridin-2(1H)-one (CAS: 545445 -44-1) me ke kūlana kiʻekiʻe, waena o Apixaban (CAS: 503612-47-3).Hiki iā Ruifu Chemical ke hāʻawi aku i ka honua holoʻokoʻa, ke kumukūʻai hoʻokūkū, ka lawelawe maikaʻi loa, ka liʻiliʻi a me ka nui nui i loaʻa.Kūʻai i nā Apixaban Intermediates,Please contact: alvin@ruifuchem.com
Inoa Kimia | 3-Morpholino-1-(4-(2-Oxopiperidin-1-yl)phenyl)-5,6-Dihydropyridin-2(1H)-one |
Nā huaʻōlelo like | Apixaban Intermediate 1;5,6-Dihydro-3-(4-Morpholinyl)-1-[4-(2-Oxo-1-Piperidinyl)phenyl]-2(1H)-Pyridinone;5-Morpholin-4-yl-1-[4-(2-Oxopiperidin-1-yl)phenyl]-2,3-Dihydropyridin-6-one;ʻO Apixaban haumia A |
Kūlana Kūʻai | Ma ke Kahua, Hana Hana Kūʻai |
Helu CAS | 545445-44-1 |
ʻĀpana Molekala | C20H25N3O3 |
Kaumaha Molecular | 355.43 g/mol |
Lae hehee | >199℃(Dek.) |
ʻO ka mānoanoa | 1.267 g/mL |
COA & MSDS | Loaʻa |
Ke kumu | Shanghai, Kina |
Māhele | Kūwaena o Apixaban (CAS: 503612-47-3) |
Brand | Kemika Ruifu |
Nā mea | Nā kikoʻī | Nā hualoaʻa |
Ka nana aku | Pauda Melemele Māmā | Pauda Melemele Māmā |
Nalo ma ka maloo | <0.50% | 0.16% |
Koena ma ka Ignition | <0.20% | 0.07% |
Maʻemaʻe / Kaʻina Hanana | >98.0% (HPLC Area) | 99.12% |
ʻO kēlā me kēia haumia kanaka | <0.50% | <0.50% |
Huina paumaele | <2.00% | 0.88% |
1H NMR Spectrum | Kūlike me ka Hoʻolālā | Kūlike |
LC-MS no ka ʻike | Kūlike | Kūlike |
Ka hopena | Ua hoʻāʻo ʻia ka huahana a hoʻokō me nā kikoʻī i hāʻawi ʻia | |
Palapala noi | Kūwaena o Apixaban (CAS: 503612-47-3) |
Pūʻolo:ʻO ka ʻōmole Fluorinated, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E hoʻopaʻa paʻa i ka pahu a mālama i loko o kahi hale kūʻai maloʻo a me ka makani maikaʻi mai nā mea like ʻole.E pale i ka malamalama a me ka wai.
Hoʻouna:Hāʻawi i ka honua ma ka lewa, e FedEx / DHL Express.Hāʻawi wikiwiki a hilinaʻi hoʻi.
Pehea e kūʻai ai?E ʻoluʻolu e kelepona maiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 mau makahiki ʻike?Loaʻa iā mākou ma mua o 15 mau makahiki o ka ʻike i ka hana ʻana a me ka hoʻokuʻu ʻana aku i kahi ākea ākea o nā intermediates pharmaceutical kiʻekiʻe a i ʻole nā kemika maikaʻi.
Mākeke Nui?E kūʻai aku i ka mākeke kūloko, ʻAmelika ʻĀkau, ʻEulopa, India, Korea, Iapana, Australia, etc.
Nā pono?ʻO ke kūlana kiʻekiʻe, ke kumukūʻai kūpono, nā lawelawe ʻoihana a me ke kākoʻo ʻenehana, ka lawe wikiwiki ʻana.
ʻAno maikaʻiHōʻoiaʻiʻo?Pūnaehana hoʻomalu maikaʻi koʻikoʻi.ʻO nā lako ʻoihana no ka nānā ʻana ʻo NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Nā laʻana?Hāʻawi ka hapa nui o nā huahana i nā laʻana manuahi no ka loiloi maikaʻi, pono e uku ʻia ke kumukūʻai e nā mea kūʻai aku.
Hooia Hale Hana?Welina mai ka loiloi hale hana.E ʻoluʻolu e hoʻopaʻa manawa ma mua.
MOQ?ʻAʻohe MOQ.ʻAe ʻia ke kauoha liʻiliʻi.
Manawa Hoʻouna? Inā i loko o ka waihona, ʻekolu lā hoʻouna ʻia.
Kaʻahele?Ma ka Express (FedEx, DHL), ma ka Air, ma ke Kai.
Nā palapala?Ma hope o ka lawelawe kūʻai: COA, MOA, ROS, MSDS, etc.
Hoʻohui Kuʻuna?Hiki ke hāʻawi i nā lawelawe synthesis maʻamau e kūpono i kāu mau pono noiʻi.
Kūkākūkā uku?E hoʻouna mua ʻia ka invoice Proforma ma hope o ka hōʻoia ʻana o ke kauoha, hoʻopili ʻia kā mākou ʻike panakō.Uku e T/T (Telex Transfer), PayPal, Western Union, etc.
ʻO 3-Morpholino-1-(4-(2-Oxopiperidin-1-yl)phenyl)-5,6-Dihydropyridin-2(1H)-one (CAS: 545445-44-1) he mea waena o Apixaban (CAS: 503612-47-3).
ʻO Apixaban kahi ʻano hou o ka waha Xa factor inhibitor i hoʻomohala pū ʻia e Bristol-Myers Squibb a me Pfizer.ʻO ka inoa kālepa ʻo Eratol, he ʻano hou o ka anticoagulant waha.Ma ke kāohi ʻana i kahi mea coagulation koʻikoʻi Xa, hiki iā Apixaban ke pale i ka hana thrombin a me ka thrombosis.Ma ʻApelila 26, 2007, hui pū ʻo Bristol-Myers Squibb me Pfizer e hoʻolaha i ka hui pū ʻana i ka hoʻomohala ʻana i kahi anticoagulant waha hou ʻo Apixaban nona Bristol-Myers Squibb ma ke ʻano he mea hou i Warfarin.I ka Mei 2011, ʻo Apixaban ka mea mua i ʻae i ka pale ʻana i ka thrombosis venous i nā poʻe maʻi makua e hana ana i ka ʻoki ʻoki ʻāʻī a i ʻole ke kuli ma 27 mau ʻāina EU, Iceland a me Norewai.Ma ka lā 20 o Nowemapa, 2012, ua ʻae ke Komisina ʻEulopa iā Ererto (Apixaban) no ka pale ʻana i ka hahau a me ka systemic embolism i nā poʻe maʻi makua me ka non-valvular atrial fibrillation (NVAF) me hoʻokahi a ʻoi aku paha nā mea pilikia.Ma hope mai, ua ʻae ka Canadian Food and Drug Administration, Iapana, a me ka US FDA iā Ererto (Apixaban) no ka pale ʻana i ka hahau a me ka systemic embolism i nā poʻe maʻi maʻi me ka non-valvular atrial fibrillation (NVAF) me hoʻokahi a ʻoi aku paha nā mea pilikia.Ma ʻApelila 12, 2013, ua hoʻolaha ʻia ka lāʻau anticoagulant hou ʻo Eloto (ELIQUIS) (Apixaban) i hui pū ʻia e Bristol-Myers Squibb a me Pfizer e hoʻopaʻa inoa ʻia ma Kina.